Correlation Between MAIA Biotechnology and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on MAIA Biotechnology and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Zentalis Pharmaceuticals.
Diversification Opportunities for MAIA Biotechnology and Zentalis Pharmaceuticals
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between MAIA and Zentalis is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Zentalis Pharmaceuticals
Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 1.13 times more return on investment than Zentalis Pharmaceuticals. However, MAIA Biotechnology is 1.13 times more volatile than Zentalis Pharmaceuticals Llc. It trades about 0.01 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.04 per unit of risk. If you would invest 354.00 in MAIA Biotechnology on August 25, 2024 and sell it today you would lose (146.00) from holding MAIA Biotechnology or give up 41.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MAIA Biotechnology vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| MAIA Biotechnology |
| Zentalis Pharmaceuticals |
MAIA Biotechnology and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MAIA Biotechnology and Zentalis Pharmaceuticals
The main advantage of trading using opposite MAIA Biotechnology and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |